Allard D, Allard B, Gaudreau PO, Chrobak P, Stagg J (2016) CD73-adenosine: a next-generation target in immuno-oncology. Immunotherapy 8:145–163. https://doi.org/10.2217/imt.15.106

Article  CAS  PubMed  Google Scholar 

Antonioli L, Fornai M, Pellegrini C, D’Antongiovanni V, Turiello R, Morello S, Haskó G, Blandizzi C (2021) Adenosine Signaling in the Tumor Microenvironment. Adv Exp Med Biol 1270:145–167. https://doi.org/10.1007/978-3-030-47189-7_9

Article  CAS  PubMed  Google Scholar 

Azambuja JH, Schuh RS, Michels LR, Gelsleichter NE, Beckenkamp LR, Lenz GS, de Oliveira FH, Wink MR, Stefani MA, Battastini AMO, Teixeira HF, Braganhol E (2020) CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model. Cancer Chemother Pharmacol 85:1177–1182. https://doi.org/10.1007/s00280-020-04077-1

Article  CAS  PubMed  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

Article  Google Scholar 

Burnstock G, Di Virgilio F (2013) Purinergic signalling and cancer. Purinergic Signalling 9:491–540. https://doi.org/10.1007/s11302-013-9372-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Fan J, Zhang M, Qin L, Dominguez D, Long A, Wang G, Ma R, Li H, Zhang Y, Fang D, Sosman J, Zhang B (2019a) CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy. Nat Commun 10:150. https://doi.org/10.1038/s41467-018-08123-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J (2019b) Nasopharyngeal carcinoma. Lancet (London England) 394:64–80. https://doi.org/10.1016/s0140-6736(19)30956-0

Article  PubMed  Google Scholar 

Furtmann N, Bajorath J (2015) Structural and modeling studies on ecto-5’-nucleotidase aiding in inhibitor design. Mini Rev Med Chem 15:34–40. https://doi.org/10.2174/1389557515666150219112630

Article  CAS  PubMed  Google Scholar 

Gao ZW, Dong K, Zhang HZ (2014) The roles of CD73 in cancer. Biomed Res Int 2014: 460654. https://doi.org/10.1155/2014/460654

Gao ZW, Wang HP, Lin F, Wang X, Long M, Zhang HZ, Dong K (2017) CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity. BMC Cancer 17:135. https://doi.org/10.1186/s12885-017-3128-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao ZW, Liu C, Yang L, Chen HC, Yang LF, Zhang HZ, Dong K (2021) CD73 severed as a potential prognostic marker and promote Lung Cancer cells Migration via enhancing EMT progression. Front Genet 12:728200. https://doi.org/10.3389/fgene.2021.728200

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giraulo C, Turiello R, Orlando L, Leonardelli S, Landsberg J, Belvedere R, Rolshoven G, Muller CE, Holzel M, Morello S (2023) The CD73 is induced by TGF-beta1 triggered by nutrient deprivation and highly expressed in dedifferentiated human melanoma. Biomed Pharmacother 165:115225. https://doi.org/10.1016/j.biopha.2023.115225

Article  CAS  PubMed  Google Scholar 

Guo J, Ma J, Zhao G, Li G, Fu Y, Luo Y, Gui R (2017) Long noncoding RNA LINC0086 functions as a tumor suppressor in nasopharyngeal carcinoma by targeting miR-214. Oncol Res 25:1189–1197. https://doi.org/10.3727/096504017x14865126670075

Article  PubMed  PubMed Central  Google Scholar 

Häusler SF, Del Barrio IM, Diessner J, Stein RG, Strohschein J, Hönig A, Dietl J, Wischhusen J (2014) Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion. Am J Translational Res 6:129–139

Google Scholar 

Jeong YM, Cho H, Kim TM, Kim Y, Jeon S, Bychkov A, Jung CK (2020) CD73 overexpression promotes progression and recurrence of papillary thyroid carcinoma. Cancers 12. https://doi.org/10.3390/cancers12103042

Jiang T, Xu X, Qiao M, Li X, Zhao C, Zhou F, Gao G, Wu F, Chen X, Su C, Ren S, Zhai C, Zhou C (2018) Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers. BMC Cancer 18:267. https://doi.org/10.1186/s12885-018-4073-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Junker A, Renn C, Dobelmann C, Namasivayam V, Jain S, Losenkova K, Irjala H, Duca S, Balasubramanian R, Chakraborty S, Börgel F, ZimMermann H, Yegutkin GG, Müller CE, Jacobson KA (2019) Structure-activity relationship of Purine and Pyrimidine Nucleotides as Ecto-5’-Nucleotidase (CD73) inhibitors. J Med Chem 62:3677–3695. https://doi.org/10.1021/acs.jmedchem.9b00164

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li S, He P, Wang Z, Liang M, Liao W, Huang Y, Chi M, Liu F, Zen N, Su R, Chen S, Liu Z, Hong H (2021) RNAi-mediated knockdown of PFK1 decreases the invasive capability and metastasis of nasopharyngeal carcinoma cell line, CNE-2. Cell cycle (Georgetown, Tex. 1–12. https://doi.org/10.1080/15384101.2020.1866279

Liao XB, Mao YP, Liu LZ, Tang LL, Sun Y, Wang Y, Lin AH, Cui CY, Li L, Ma J (2008) How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? Int J Radiat Oncol Biol Phys 72:1368–1377. https://doi.org/10.1016/j.ijrobp.2008.03.017

Article  PubMed  Google Scholar 

Lupia M, Angiolini F, Bertalot G, Freddi S, Sachsenmeier KF, Chisci E, Kutryb-Zajac B, Confalonieri S, Smolenski RT, Giovannoni R, Colombo N, Bianchi F, Cavallaro U (2018) CD73 regulates stemness and epithelial-mesenchymal transition in ovarian Cancer-initiating cells. Stem cell Reports 10:1412–1425. https://doi.org/10.1016/j.stemcr.2018.02.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma XL, Shen MN, Hu B, Wang BL, Yang WJ, Lv LH, Wang H, Zhou Y, Jin AL, Sun YF, Zhang CY, Qiu SJ, Pan BS, Zhou J, Fan J, Yang XR, Guo W (2019) CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. J Hematol Oncol 12:37. https://doi.org/10.1186/s13045-019-0724-7

Article  PubMed  PubMed Central  Google Scholar 

Ohana G, Bar-Yehuda S, Barer F, Fishman P (2001) Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. J Cell Physiol 186:19–23. https://doi.org/10.1002/1097-4652(200101)186:1<19::aid-jcp1011>3.0.co;2-3

Qian CN, Mei Y, Zhang J (2017) Cancer metastasis: issues and challenges. Chin J cancer 36:38. https://doi.org/10.1186/s40880-017-0206-7

Article  PubMed  PubMed Central  Google Scholar 

Ren ZH, Lin CZ, Cao W, Yang R, Lu W, Liu ZQ, Chen YM, Yang X, Tian Z, Wang LZ, Li J, Wang X, Chen WT, Ji T, Zhang CP (2016) CD73 is associated with poor prognosis in HNSCC. Oncotarget 7:61690–61702. https://doi.org/10.18632/oncotarget.11435

Article  PubMed  PubMed Central  Google Scholar 

Sadej R, Skladanowski AC (2012) Dual, enzymatic and non-enzymatic, function of ecto-5’-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells. Acta Biochim Pol 59:647–652

Article  CAS  PubMed  Google Scholar 

Sciarra A, Monteiro I, Ménétrier-Caux C, Caux C, Gilbert B, Halkic N, La Rosa S, Romero P, Sempoux C, de Leval L (2019) CD73 expression in normal and pathological human hepatobiliopancreatic tissues. Cancer Immunol Immunotherapy: CII 68:467–478. https://doi.org/10.1007/s00262-018-2290-1

Article  CAS  PubMed  Google Scholar 

Shi S, Li X, You B, Shan Y, Cao X, You Y (2015) High expression of FGFR4 enhances Tumor Growth and Metastasis in Nasopharyngeal Carcinoma. J Cancer 6:1245–1254. https://doi.org/10.7150/jca.12825

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soleimani A, Taghizadeh E, Shahsavari S, Amini Y, Rashidpour H, Azadian E, Jafari A, Parizadeh MR, Mashayekhi K, Soukhtanloo M, Jaafari MR (2019) CD73; a key ectonucleotidase in the development of breast cancer: recent advances and perspectives. J Cell Physiol 9:14622–14632. https://doi.org/10.1002/jcp.28187

Article  CAS  Google Scholar 

Soleimani A, Farshchi HK, Mirzavi F, Zamani P, Ghaderi A, Amini Y, Khorrami S, Mashayekhi K, Jaafari MR (2020) The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma. Biochimie 176:21–30. https://doi.org/10.1016/j.biochi.2020.06.001

Article  CAS  PubMed  Google Scholar 

Sun Y, Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, Sun Y, Chen XZ, Li JG, Zhu XD, Hu CS, Xu XY, Chen YY, Hu WH, Guo L, Mo HY, Chen L, Mao YP, Sun R, Ai P et al (2016) Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol 17:1509–1520. https://doi.org/10.1016/s1470-2045(16)30410-7

Article  CAS  PubMed  Google Scholar 

Tang Z, Kang B, Li C, Chen T, Zhang Z (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47:W556–w560. https://doi.org/10.1093/nar/gkz430

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tripathi A, Lin E, Xie W, Flaifel A, Steinharter JA, Stern Gatof EN, Bouchard G, Fleischer JH, Martinez-Chanza N, Gray C, Mantia C, Thompson L, Wei XX, Giannakis M, McGregor BA, Choueiri TK, Agarwal N, McDermott DF, Signoretti S, Harshman LC (2020) Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. J Immunotherapy cancer 8. https://doi.org/10.1136/jitc-2020-001467

Article  Google Scholar 

Xu Z, Gu C, Yao X, Guo W, Wang H, Lin T, Li F, Chen D, Wu J, Ye G, Zhao L, Hu Y, Yu J, Shi J, Li G, Liu H (2020) CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer. Cell Death Dis 11:202. https://doi.org/10.1038/s41419-020-2403-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue F, Wang T, Shi H, Feng H, Feng G, Wang R, Yao Y, Yuan H (2022) CD73 facilitates invadopodia formation and boosts malignancy of head and neck squamous cell carcinoma via the MAPK signaling pathway. Cancer Sci 113:2704–2715. https://doi.org/10.1111/cas.15452

Article